|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.650 GBX | 0.00% |
|
0.00% | -48.59% |
| 20/11 | Poolbeg Pharma Secures European Patent for Severe Influenza Drug Candidate | MT |
| 20/11 | AIM WINNERS & LOSERS: Artisanal in shutdown hit; Solid State deal wins | AN |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | -3.69x | 3.04x | - | -3.39x | -3.15x | 3.39Cr | ||
| -.--% | -.--% | 50.09x | 8.14x | 12.19x | 43.93x | 45.2x | 5.49TCr | ||
| -.--% | -.--% | -33.09x | 66.12x | 83.99x | -37.13x | -36.57x | 4.35TCr | ||
| 1.77% | 1.68% | 15.99x | 3.77x | 5.59x | 12.68x | 13.86x | 3.81TCr | ||
| -.--% | -.--% | -25.55x | 1.1x | 3.4x | -9.97x | -7.59x | 2.31TCr | ||
| -.--% | -.--% | 17.37x | 3.28x | 4.28x | 11.35x | 12.11x | 1.95TCr | ||
| -.--% | -.--% | 27.5x | 2.54x | 5.38x | 14.92x | 18.58x | 1.73TCr | ||
| -.--% | -.--% | -513.11x | 14.06x | 29.69x | 700.16x | -597.17x | 1.47TCr | ||
| -.--% | -.--% | -14.2x | - | 178.64x | -27.85x | -13.87x | 1.41TCr | ||
| -.--% | -.--% | -197x | 23.8x | 48.58x | -193.78x | -167.83x | 1.38TCr | ||
| -.--% | -.--% | -58.84x | 21.72x | 13.23x | -56.08x | -50.56x | 1.31TCr | ||
| -.--% | -.--% | 17.41x | 4.57x | 4.86x | 12.08x | 13.57x | 1.19TCr | ||
| -.--% | -.--% | -19.14x | 9.09x | - | -19.74x | -19.07x | 851.12Cr | ||
| -.--% | -.--% | -18.6x | 15.44x | 18.52x | -28.7x | -18.01x | 834.41Cr | ||
| -.--% | -.--% | -10.39x | -15.86x | 90.86x | -12.75x | -12.48x | 802.91Cr | ||
| -.--% | -.--% | -16.41x | 12.82x | 125.36x | -19.07x | -18.57x | 729.17Cr | ||
| Average | 0.12% | 0.11% | -48.85x | 11.58x | 44.61x | 24.17x | -52.60x | 1.85TCr | |
| Weighted average by Cap. | 0.23% | 0.22% | -31.71x | 16.47x | 36.32x | 25.33x | -35.53x |
- Stock Market
- Equities
- POLB Stock
- Sector Poolbeg Pharma PLC
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















